Clinical trial

Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia

NCT01712646

Study summary

ClinicalTrials.gov

Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1, PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Intranasal Oxytocin Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2012-10-05

PhasePHASE1 / PHASE2

Conditions

Childhood Onset Psychotic Disordersunresolved

Schizophreniaverified · MONDO: schizophrenia

Interventions

Intranasal OxytocinDRUG

Sponsors & collaborators

National Institute of Mental Health (NIMH)lead sponsor

Mapped research locations

BethesdaMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01712646 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.